NCT00019539 2024-03-04Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney CancerNational Cancer Institute (NCI)Phase 2 Completed
NCT00277017 2011-09-27Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell CarcinomaNew Mexico Cancer Research AlliancePhase 1/2 Completed15 enrolled
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled
NCT00005966 2009-02-05Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney CancerNational Cancer Institute (NCI)Phase 3 Completed